Alnylam Pharma Stock Performance
as on September 5, 2026 at 3:18 am IST
Day's Low
Day's High
$258.44$266.81
2.59%
Downside
0.57%
Upside
52 Week's Low
52 Week's High
$197.81$495.5525.44%
Downside
86.78%
Upside
Alnylam Pharma share price movements today
- Previous Close
- $264.50
- Open
- $258.56
- Volume
- 462.4K
- Market Cap
- $35.8B
- Day's Low - High
- $258.44 - $266.81
- 52 Week Low - High
- $197.81 - $495.55
Alnylam Pharma Historical Returns
- 1 Month Return
- + 20.78 %
- 3 Month Return
- -12.89 %
- 1 Year Return
- -41.68 %
- 3 Year Return
- + 31.48 %
- 5 Year Return
- + 33.95 %
Alnylam Pharma Stock Fundamentals & Key Indicators
Check Alnylam Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$35.8B
EPS (TTM)
8.9154
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
42.92
Industry PE ratio
9.70
PEG Ratio
0.3177
EBITDA
1.1B
Revenue (TTM)
4.8B
Profit Margin
16.13%
Return On Equity TTM
96.56%
Alnylam Pharma Stock Valuation
Track how Alnylam Pharma P/E has moved over time to understand its valuation trends.
Alnylam Pharma in the last 5 years
Lowest (-99.61x)
December 31, 2023
Industry (9.70x)
September 4, 2026
Today (42.92x)
September 4, 2026
Highest (124.53x)
September 30, 2025
Today’s Price to Earnings Ratio: 42.92x
Alnylam Pharma vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Alnylam Pharma with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $35.8B | 33.95% | 42.92 | 16.13% | NA | |
| BUY | $44.6B | 614.61% | NA | 0.00% | NA | |
| BUY | $141.1B | 181.73% | 32.21 | 86.04% | NA | |
| BUY | $60.2B | -64.27% | -18.66 | -12.57% | NA | |
| BUY | $84.8B | 24.12% | 20.14 | 84.86% | 0.44% |
Stock Returns calculator for Alnylam Pharma Stock including INR - Dollar returns
The Alnylam Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Alnylam Pharma investment value today
Current value as on today
₹62,671
Returns
Returns from Alnylam Pharma Stock
Dollar Impact
₹4,173 (+4.17%)
Analyst Recommendation on Alnylam Pharma Stock
Based on 22 analysts
86.36%
Buy
13.64%
Hold
0.00%
Sell
Based on 22 analysts, 86.36363636363636% of analysts recommend a 'BUY' rating for Alnylam Pharma. Average target price of $370.2
Alnylam Pharma Share Price Target
Get share price movements and forecasts by analysts on Alnylam Pharma.
What analysts predicted
28.33%UPSIDE
Target Price
$370.2
Current Price
$265.31
Analyzed by
22 Analysts
Target
$370.20
Alnylam Pharma target price $370.2, a slight upside of 28.33% compared to current price of $265.31. According to 22 analysts rating.
Indian Investors' Interest in Alnylam Pharma Stock
Investment in Alnylam Pharma Shares on INDmoney has dropped by -57.73% in the last 30 days, indicating reduced investment activity.
Time period: to
Search interest for Alnylam Pharma Stock has increased by 78% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:78% versus previous 30 day period
Alnylam Pharma Quarterly Profit & Loss
All numbers in Millions USD
Alnylam Pharma Annual Profit & Loss
All numbers in Millions USD
Alnylam Pharma Quarterly Cash Flow
All numbers in Millions USD
Alnylam Pharma Annual Cash Flow
All numbers in Millions USD
Alnylam Pharma News & Key Events
Today's Timeline - 02 September
Wed, 05:30 PM
-Alnylam announces presentations at two September investor conferences with live webcasts available on their website.
Insights on Alnylam Pharma
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 1.09B → 1.29B (in $), with an average increase of 7.8% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, ALNY stock has moved up by 11.6%
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 513.1% return, outperforming this stock by 554.8%
- NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 32.3% return, outperforming this stock by 0.8%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 205.99M → 164.49M (in $), with an average decrease of 20.2% per quarter
About Alnylam Pharma
| Organisation | Alnylam Pharma |
| Headquarters | 675 West Kendall Street, Cambridge, MA, United States, 02142 |
| Industry | Biotechnology |
| CEO | Dr. Yvonne L. Greenstreet M.B.A., M.D. |
| E-voting on shares | Click here to vote |
Key Management of Alnylam Pharma
Name | Title |
|---|---|
Mr. Bryan Andrew Supran J.D. | Chief Legal Officer |
Mr. Joshua Brodsky | Vice President of Investor Relations |
Mr. Jeffrey V. Poulton M.B.A. | CFO & Executive VP |
Dr. Pushkal P. Garg M.D. | Executive VP & Chief Research & Development Officer |
Mr. Tolga Tanguler M.B.A. | Executive VP & Chief Commercialization Officer |
Mr. Timothy J. Maines | Chief Technical Operations & Quality Officer |
Dr. Kevin Joseph Fitzgerald Ph.D. | Executive VP, Chief Scientific Officer and Head of Early Research & Early Development |
Mr. Piyush Sharma J.D. | Chief Ethics & Compliance Officer |
Dr. Yvonne L. Greenstreet M.B.A., M.D. | CEO & Director |
Dr. Phillip A. Sharp Ph.D. | Co-Founder, Member of the Scientific Advisory Board |
FAQs
What is Alnylam Pharma share price today?
Alnylam Pharma share price today is $265.31 as on . Alnylam Pharma share today touched a day high of $266.81 and a low of $258.44.
What is the 52 week high and 52 week low for Alnylam Pharma share?
Alnylam Pharma share touched a 52 week high of $495.55 on and a 52 week low of $197.81 on . Alnylam Pharma stock price today i.e. is trending at $265.31,which is 46.46% down from its 52 week high and 34.12% up from its 52 week low.
What is Alnylam Pharma's market capitalisation today?
Alnylam Pharma market capitalisation is $0.04T as on .
How to invest in Alnylam Pharma Stock (ALNY) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Alnylam Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alnylam Pharma Shares that will get you 0.0057 shares as per Alnylam Pharma share price of $265.31 per share as on September 4, 2026 at 9:48 pm IST.
What is the minimum amount required to buy Alnylam Pharma Stock (ALNY) from India?
Indian investors can start investing in Alnylam Pharma (ALNY) shares with as little as ₹94.485 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.85 in Alnylam Pharma stock (as per the Rupee-Dollar exchange rate as on ).
Based on Alnylam Pharma share’s latest price of $265.31 as on September 4, 2026 at 9:48 pm IST, you will get 0.0377 shares of Alnylam Pharma. Learn more about
fractional shares .
What are the returns that Alnylam Pharma has given to Indian investors in the last 5 years?
Alnylam Pharma stock has given 33.95% share price returns and 29.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?